株探米国株
日本語 英語
エドガーで原本を確認する
0000785786false00007857862025-07-232025-07-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________________________________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
____________________________________________________________________________________________________________________________________
Date of Report (Date of earliest event reported): July 23, 2025
____________________________________________________________________________________________________________________________________
plxslogo8ka05.gif
PLEXUS CORP.
(Exact name of registrant as specified in its charter)
____________________________________________________________________________________________________________________________________
Wisconsin 001-14423 39-1344447
(State or other jurisdiction
 of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
One Plexus Way
Neenah, Wisconsin 54957
(Address of principal executive offices) (Zip Code)
Telephone Number (920) 969-6000
(Registrant’s telephone number, including Area Code) 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, $0.01 par value PLXS The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
        If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐



Item 2.02    Results of Operations and Financial Condition.

On July 23, 2025, Plexus Corp. (“we” or the “Company”) announced results for the fiscal third quarter ended June 28, 2025. A copy of the Company’s related press release is furnished as Exhibit 99.1 to this report.


Item 9.01    Financial Statements and Exhibits

(d) The following exhibits are filed herewith:

Exhibit Number Description
99.1
104 Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document)





* * * * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 23, 2025 PLEXUS CORP.
(Registrant)
By: /s/ Patrick J. Jermain
Patrick J. Jermain
Executive Vice President and Chief Financial Officer


EX-99.1 2 plxsf25q3earningsrelease-e.htm EX-99.1 Document

plexusprlogo_1a.gif
Plexus Announces Fiscal Third Quarter Financial Results
NEENAH, WI – July 23, 2025 - Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended June 28, 2025, and guidance for our fiscal fourth quarter ending September 27, 2025.
•Reports fiscal third quarter 2025 revenue of $1.018 billion, GAAP operating margin of 5.3% and GAAP diluted EPS of $1.64.
•Reports fiscal third quarter 2025 non-GAAP operating margin of 6.0% and non-GAAP diluted EPS of $1.90, excluding $0.26 of stock-based compensation expense.
•Initiates fiscal fourth quarter 2025 revenue guidance of $1.025 billion to $1.065 billion with GAAP diluted EPS of $1.57 to $1.72, including $0.25 of stock-based compensation expense. Fiscal fourth quarter non-GAAP EPS guidance of $1.82 to $1.97 excludes stock-based compensation expense.
Three Months Ended
Jun 28, 2025 Jun 28, 2025 Sep 27, 2025
Q3F25 Results
Q3F25 Guidance
Q4F25 Guidance
Summary GAAP Items
Revenue (in billions) $1.018 $1.000 to $1.040 $1.025 to $1.065
Operating margin 5.3  % 5.0% to 5.4% 5.0% to 5.4%
Diluted EPS $1.64 $1.40 to $1.55 $1.57 to $1.72
Summary Non-GAAP Items (1)
Adjusted operating margin (2) 6.0  % 5.7% to 6.1% 5.7% to 6.1%
Adjusted EPS (3) $1.90 $1.65 to $1.80 $1.82 to $1.97
Return on invested capital (ROIC) 14.1  %
Economic return 5.2  %
(1) Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.
(2)
Excludes stock-based compensation expense of approximately 70 bps for Q3F25 results, Q3F25 guidance and Q4F25 guidance.
(3)
Excludes stock-based compensation expense, net of tax, of $0.26 for Q3F25 results and $0.25 for Q3F25 guidance and Q4F25 guidance.
Fiscal Third Quarter 2025 Information
•Won 41 manufacturing programs during the quarter representing $250 million in annualized revenue when fully ramped into production.
•Generated fiscal third quarter free cash flow of $13.2 million, contributing to fiscal year-to-date free cash flow of $56.8 million.
•Purchased $18.4 million of our shares at an average price of $128.70 per share during the quarter.
•As previously announced on May 14, 2025, Plexus' Board of Directors approved a new $100.0 million share repurchase program. Plexus has recently begun repurchasing shares under this $100.0 million program as the previous $50.0 million program has been fulfilled.







Todd Kelsey, President and Chief Executive Officer, commented, “Our Plexus team continues to execute at a high level in driving numerous efficiency initiatives, which resulted in another strong quarter of financial performance. Fiscal third quarter revenue of $1.018 billion grew sequentially and was in-line with guidance, non-GAAP operating margin of 6.0% was near the high end of guidance and non-GAAP EPS of $1.90 exceeded guidance. Furthermore, free cash flow again surpassed our expectations.”

Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, "Fiscal third quarter cash cycle of 69 days was consistent with expectations and one day higher than the fiscal second quarter. For the sixth consecutive quarter, we drove a reduction in our gross inventory balance. This result, combined with other improvements to our cash cycle and our strong operating performance, produced fiscal third quarter return on invested capital of 14.1%, which exceeded our weighted average cost of capital by 520 basis points. We also delivered better than anticipated free cash flow of $13.2 million in support of our expectation to achieve approximately $100 million in free cash flow for fiscal 2025. Finally, furthering our commitment to return cash to our shareholders, we repurchased $18.4 million of our shares during the fiscal third quarter, while adding a $100 million share repurchase program to our previous, now fully-utilized, $50 million program."

Mr. Kelsey added, “Our go-to-market team secured 41 fiscal third quarter manufacturing wins with well-balanced market sector diversification, representing $250 million in annualized revenue. Included in these wins are share gains resulting from our sustained focus on zero defects and perfect delivery as well as new customers in each of our market sectors with products aligned to exciting growth technologies.”

Mr. Kelsey continued, “We expect to deliver strong fiscal fourth quarter financial results, including further sequential revenue growth. We anticipate generating this revenue expansion through share gains, new program ramps and growth with new customers, while overcoming muted end market demand, evolving new program ramp timelines and uncertainties created by tariffs. We are guiding revenue of $1.025 to $1.065 billion, non-GAAP operating margin of 5.7% to 6.1% and non-GAAP EPS of $1.82 to $1.97. At the midpoint, our fiscal fourth quarter guidance would result in robust non-GAAP fiscal 2025 EPS growth of 26%.”

Mr. Kelsey concluded, “We are committed to creating long-term shareholder value through enabling customer success and focused initiatives that drive organizational and operational efficiency. We are bullish on the growth opportunities our solutions and market sectors provide. Our strategy is creating opportunities to gain share and capture new outsourcing opportunities in support of delivering sustained strong financial performance and growth exceeding that of our end markets.”

2


Quarterly Comparison Three Months Ended
(in thousands, except EPS) Jun 28, 2025 Mar 29, 2025 Jun 29, 2024
Revenue $ 1,018,308  $ 980,170  $ 960,751 
Gross profit 103,288  97,751  94,415 
Operating income 53,608  48,791  39,246 
Net income 45,116  39,073  25,140 
Diluted EPS $ 1.64  $ 1.41  $ 0.91 
Gross margin 10.1  % 10.0  % 9.8  %
Operating margin 5.3  % 5.0  % 4.1  %
ROIC (1) 14.1  % 13.7  % 10.4  %
Economic return (1) 5.2  % 4.8  % 2.2  %
(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.
Business Segment and Market Sector Revenue
Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised 48% of revenue during the third quarter of both fiscal 2025 and 2024, which is down three percentage points from the second quarter of fiscal 2025.

Business Segments ($ in millions) Three Months Ended
Jun 28, 2025 Mar 29, 2025 Jun 29, 2024
Americas $ 312  $ 295  $ 306 
Asia-Pacific 594  587  521 
Europe, Middle East and Africa 117  103  137 
Elimination of inter-segment sales (5) (5) (3)
Total Revenue $ 1,018  $ 980  $ 961 

Market Sectors ($ in millions) Three Months Ended
Jun 28, 2025 Mar 29, 2025 Jun 29, 2024
Aerospace/Defense $ 183  18  % $ 172  18  % $ 178  18  %
Healthcare/Life Sciences 420  41  % 411  42  % 380  40  %
Industrial 415  41  % 397  40  % 403  42  %
Total Revenue $ 1,018  $ 980  $ 961 

3


Non-GAAP Supplemental Information
Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.

ROIC and Economic Return
ROIC for the third quarter of fiscal 2025 was 14.1%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a four-quarter period for the third fiscal quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus' weighted average cost of capital for fiscal 2025 is 8.9%. ROIC for the third quarter of fiscal 2025 less Plexus’ weighted average cost of capital resulted in an economic return of 5.2%.

Free Cash Flow
Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended June 28, 2025, cash flows provided by operations was $26.9 million, less capital expenditures of $13.7 million, resulting in free cash flow of $13.2 million.

Cash Cycle Days Three Months Ended
Jun 28, 2025 Mar 29, 2025 Jun 29, 2024
Days in Accounts Receivable 59 57 61
Days in Contract Assets 13 12 11
Days in Inventory 128 132 151
Days in Accounts Payable (72) (70) (62)
Days in Advanced Payments (59) (63) (78)
Annualized Cash Cycle (1) 69 68 83
(1) Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.


4


Conference Call and Webcast Information
What:
Plexus Fiscal 2025 Q3 Earnings Conference Call and Webcast
When:
Thursday, July 24, 2025 at 8:30 a.m. Eastern Time
Where:
Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below:

Webcast link:
https://events.q4inc.com/attendee/103729490
Replay:
The webcast will be archived on the Plexus website and will be available as on-demand for 12 months
Investor and Media Contact
Shawn Harrison
+1.920.969.6325
shawn.harrison@plexus.com
About Plexus
Since 1979, Plexus has helped create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 26 facilities in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions. For more information about Plexus, visit our website at www.plexus.com.
Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2024 Form 10-K.
5


PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended Nine Months Ended
Jun 28, Jun 29, Jun 28, Jun 29,
2025 2024 2025 2024
Net sales $ 1,018,308  $ 960,751  $ 2,974,600  $ 2,910,258 
Cost of sales 915,020  866,336  2,672,869  2,639,640 
Gross profit 103,288  94,415  301,731  270,618 
Operating expenses:
Selling and administrative expenses 49,680  45,950  147,789  136,487 
Restructuring and other charges, net —  9,219  4,683  20,257 
Operating income 53,608  39,246  149,259  113,874 
Other income (expense):
Interest expense (2,501) (7,389) (9,192) (23,299)
Interest income 934  1,015  3,039  2,640 
Miscellaneous, net (2,205) (2,568) (4,753) (9,097)
Income before income taxes 49,836  30,304  138,353  84,118 
Income tax expense 4,720  5,164  16,897  13,524 
Net income
$ 45,116  $ 25,140  $ 121,456  $ 70,594 
Earnings per share:
Basic $ 1.67  $ 0.92  $ 4.48  $ 2.57 
Diluted $ 1.64  $ 0.91  $ 4.39  $ 2.53 
Weighted average shares outstanding:
Basic 27,059  27,364  27,084  27,463 
Diluted 27,532  27,765  27,670  27,918 


6


PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
(unaudited)
Jun 28, Sep 28,
2025 2024
ASSETS
Current assets:
Cash and cash equivalents $ 237,567  $ 345,109 
Restricted cash 50  2,353 
Accounts receivable 663,549  622,366 
Contract assets 145,145  120,560 
Inventories 1,278,219  1,311,434 
Prepaid expenses and other 70,538  75,328 
Total current assets 2,395,068  2,477,150 
Property, plant and equipment, net 534,560  501,112 
Operating lease right-of-use assets 74,741  74,360 
Deferred income taxes 73,550  73,919 
Other assets 27,714  27,280 
Total non-current assets 710,565  676,671 
Total assets $ 3,105,633  $ 3,153,821 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and finance lease obligations $ 50,678  $ 157,325 
Accounts payable 722,270  606,378 
Advanced payments from customers 592,512  709,152 
Accrued salaries and wages 89,797  94,448 
Other accrued liabilities 61,196  75,991 
Total current liabilities 1,516,453  1,643,294 
Long-term debt and finance lease obligations, net of current portion 92,215  89,993 
Accrued income taxes payable —  17,198 
Long-term operating lease liabilities 31,192  32,275 
Deferred income taxes 5,986  8,234 
Other liabilities 40,702  38,002 
Total non-current liabilities 170,095  185,702 
Total liabilities 1,686,548  1,828,996 
Shareholders’ equity:
Common stock 547  545 
Additional paid-in-capital 688,002  680,638 
Common stock held in treasury (1,233,922) (1,190,115)
Retained earnings 1,944,599  1,823,143 
Accumulated other comprehensive income 19,859  10,614 
Total shareholders’ equity 1,419,085  1,324,825 
Total liabilities and shareholders’ equity $ 3,105,633  $ 3,153,821 

7


PLEXUS CORP. AND SUBSIDIARIES
NON-GAAP SUPPLEMENTAL INFORMATION Table 1
(in thousands, except per share data)
(unaudited)
Three Months Ended Nine Months Ended
Jun 28, Mar 29, Jun 29, Jun 28, Jun 29,
2025 2025 2024 2025 2024
Operating income, as reported $ 53,608  $ 48,791  $ 39,246  $ 149,259  $ 113,874 
Operating margin, as reported 5.3  % 5.0  % 4.1  % 5.0  % 3.9  %
Non-GAAP adjustments:
Restructuring costs (1) —  —  9,219  4,683  22,507 
Other non-recurring income (2) —  —  —  —  (2,250)
Stock-based compensation 7,691  7,132  7,205  21,813  19,636 
Non-GAAP operating income $ 61,299  $ 55,923  $ 55,670  $ 175,755  $ 153,767 
Non-GAAP operating margin 6.0  % 5.7  % 5.8  % 5.9  % 5.3  %
Net income, as reported $ 45,116  $ 39,073  $ 25,140  $ 121,456  $ 70,594 
Non-GAAP adjustments:
Restructuring costs, net of tax (1) —  —  8,251  4,191  20,144 
Other non-recurring income, net of tax (2) —  —  —  —  (2,014)
Stock-based compensation, net of tax 7,307  6,775  6,845  20,722  19,276 
Adjusted net income $ 52,423  $ 45,848  $ 40,236  $ 146,369  $ 108,000 
Diluted earnings per share, as reported $ 1.64  $ 1.41  $ 0.91  $ 4.39  $ 2.53 
Non-GAAP per share adjustments:
Restructuring costs, net of tax (1) —  —  0.30  0.15  0.72 
Other non-recurring income, net of tax (2) —  —  —  —  (0.07)
Stock-based compensation, net of tax 0.26  0.25  0.24  0.75  0.69 
Adjusted diluted earnings per share $ 1.90  $ 1.66  $ 1.45  $ 5.29  $ 3.87 
(1) During the three months ended June 29, 2024, restructuring and impairment charges of $9.2 million, or $8.3 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company’s workforce as well as closure costs associated with a site in the Company’s AMER region.

During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company’s workforce in the EMEA and AMER regions.

During the nine months ended June 29, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.
(2) During the nine months ended June 29, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.
8


PLEXUS CORP. AND SUBSIDIARIES
NON-GAAP SUPPLEMENTAL INFORMATION Table 2
 (in thousands)
(unaudited)
ROIC and Economic Return Calculations Nine Months Ended Six Months Ended Nine Months Ended
Jun 28, Mar 29, Jun 29,
2025 2025 2024
Operating income, as reported $ 149,259  $ 95,651  $ 113,874 
Restructuring and other charges, net 4,683  4,683  20,257 
Accelerated stock-based compensation (1) + —  + —  + 892 
Adjusted operating income $ 153,942  $ 100,334  $ 135,023 
÷ 3 x 2 ÷ 3
$ 51,314  $ 45,008 
x 4 x 4
Adjusted annualized operating income $ 205,256  $ 200,668  $ 180,032 
Adjusted effective tax rate x 11  % x 13  % x 16  %
Tax impact 22,578  26,087  28,805 
Adjusted operating income (tax-effected) $ 182,678  $ 174,581  $ 151,227 
Average invested capital ÷ $ 1,298,575  ÷ $ 1,276,742  ÷ $ 1,454,871 
ROIC 14.1  % 13.7  % 10.4  %
Weighted average cost of capital - 8.9  % - 8.9  % - 8.2  %
Economic return 5.2  % 4.8  % 2.2  %
Average Invested Capital Calculations Jun 28, Mar 29, Dec 28, Sep 28,
2025 2025 2024 2024
Equity $ 1,419,085  $ 1,351,675  $ 1,319,069  $ 1,324,825 
Plus:
Debt and finance lease obligations - current 50,678  121,014  121,977  157,325 
Operating lease obligations - current (2) 8,470  9,968  14,875  14,697 
Debt and finance lease obligations - long-term
92,215  88,761  88,728  89,993 
Operating lease obligations - long-term 31,192  32,720  35,124  32,275 
Less: Cash and cash equivalents (237,567) (310,531) (317,161) (345,109)
$ 1,364,073  $ 1,293,607  $ 1,262,612  $ 1,274,006 
Average Invested Capital Calculations Jun 29, Mar 30, Dec 30, Sep 30,
2024 2024 2023 2023
Equity $ 1,266,360  $ 1,259,762  $ 1,266,755  $ 1,214,382 
Plus:
Debt and finance lease obligations - current 258,175  245,964  251,119  240,205 
Operating lease obligations - current (2) 7,990  8,281  9,172  8,363 
Debt and finance lease obligations - long-term
90,715  192,025  192,118  190,853 
Operating lease obligations - long-term 31,923  33,915  35,989  38,552 
Less: Cash and cash equivalents (269,868) (265,053) (231,982) (256,233)
$ 1,385,295  $ 1,474,894  $ 1,523,171  $ 1,436,122 
(1) During the nine months ended June 29, 2024, $0.9 million of accelerated stock-based compensation expense was recorded in selling and administrative expense in the accompanying Condensed Consolidated Statements of Operations as a result of a previously announced executive retirement agreement.
(2) Included in other accrued liabilities on the Condensed Consolidated Balance Sheets.
9